Venous Thromboembolism: Understanding DVT and Pulmonary Embolism
Updated: 3 days ago
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026
Venous Thromboembolism (VTE) is a serious vascular condition involving blood clots that form in the veins. It encompasses two related disorders: Deep Vein Thrombosis (DVT), where a clot forms in a deep vein (usually the leg), and Pulmonary Embolism (PE), where a clot travels to the lungs. As the third most common vascular diagnosis in the United States, VTE requires prompt recognition of symptoms like swelling and chest pain [1]. Early diagnosis through imaging and treatment with anticoagulants are essential to prevent life-threatening complications.
Quick Answer
Venous thromboembolism (VTE) is a condition in which a blood clot blocks blood flow in a vein, most commonly in the legs (DVT), and it can be fatal if the clot travels to the lungs (PE) [1]. Risk factors include surgery, cancer and immobilization [1]. Diagnosis uses D-dimer tests and ultrasound, and blood thinners treat clots and prevent new ones [1].
What the research says
Ultrasound and D-dimer play different roles in suspected DVT. A systematic review of 43 diagnostic studies found proximal compression ultrasound had pooled sensitivity of 90.1% (95% CI 86.5-92.8) and specificity of 98.5% (95% CI 97.6-99.1), whole-leg ultrasound 94.0% and 97.3%, and D-dimer 96.1% sensitivity but only 35.7% specificity, so a positive D-dimer needs confirmation with imaging (Bhatt et al., Blood Advances, 2020) [2].
A negative D-dimer can safely rule out VTE in lower-risk pregnancy. A meta-analysis of 4 studies found a 3-month thromboembolic rate of 0.32% (1/312; 95% CI 0.06-1.83) in pregnant women left untreated after a negative D-dimer, with pooled sensitivity of 99.5% (95% CI 95.0-100.0), in women with a low or intermediate (unlikely) pretest probability (Bellesini et al., Journal of Thrombosis and Haemostasis, 2021) [3].
Recurrence risk after hormone-related VTE is low once treatment ends. A meta-analysis of 14 studies found a pooled recurrence rate of 1.57 per 100 patient-years (95% CI 1.10-2.23) after stopping anticoagulation in women whose first VTE was related to estrogen-containing contraceptives, which the authors say favors short-term anticoagulation (Wiegers et al., Journal of Thrombosis and Haemostasis, 2022) [4].
What is Venous Thromboembolism?
Venous Thromboembolism (VTE) is a comprehensive medical term used to describe a disorder where blood clots form in the venous system. The term combines "thrombo," meaning blood clot, and "embolism," which refers to a circulating particle that causes an obstruction. Unlike arterial clots, which are the primary cause of heart attacks and strokes, VTE affects the veins that carry blood back to the heart and lungs [1].
VTE manifests in two primary forms:
In the United States, VTE is a major health concern, ranking as the third most common vascular diagnosis [1]. It affects approximately 1 in 1,000 Americans annually, with nearly half of those patients experiencing a pulmonary embolism [1].
Causes and Mechanisms of Clotting
Blood clotting is a natural and healthy response to injury, designed to prevent excessive bleeding. However, VTE occurs when this process is triggered inappropriately or when a clot fails to dissolve after a wound has healed [1]. Clots can be sparked by infections that irritate vessel linings or by stagnant blood flow [1].
When a vein is blocked, blood pools behind the obstruction, leading to inflammation and tissue damage. If the blockage occurs in the lungs, it restricts oxygen flow and increases blood pressure in the arteries, which can lead to heart failure [1]. Statistically, about 25% of individuals who suffer a pulmonary embolism die from the condition [1].
Identifying Risk Factors
While 25% to 50% of VTE cases occur without an obvious cause, several factors significantly increase an individual's risk [1]. These range from medical history to lifestyle choices.
Risk Category | Common Factors |
Medical History | Recent surgery (20% of cases), cancer (20%), and bone fractures [1]. |
Hormonal Changes | High estrogen from pregnancy, birth control, or hormone replacement therapy [1]. |
Lifestyle | Prolonged immobilization (long-distance travel), obesity, and smoking [1]. |
Chronic Illness | Heart disease, inflammatory bowel disease (IBD), and blood disorders [1]. |
Demographics | Age over 40, with the risk nearly doubling every decade thereafter [1]. |
Recognizing the Symptoms
The symptoms of VTE depend on whether the clot is stationary in a limb or has traveled to the lungs. Recognizing these signs early can be the difference between a routine recovery and a fatal event.
Deep Vein Thrombosis (DVT) Signs
DVT symptoms occur at the site of the clot, most frequently in the leg. Patients should look for localized swelling, redness, warmth, and persistent pain or tenderness [1].
Pulmonary Embolism (PE) Signs
PE can occur suddenly, sometimes without any prior symptoms of DVT [1]. Emergency signs include sharp chest pain, sudden shortness of breath, a rapid heart rate, and lightheadedness [1]. In severe cases, a patient may cough up blood or lose consciousness [1].
The Diagnostic Pathway
To confirm VTE, healthcare providers utilize a combination of blood work and specialized imaging. The goal is to locate the clot and assess the risk of it traveling to the lungs.
Common diagnostic tools include:
D-dimer Test: A blood test that measures a substance released when blood clots dissolve [1]. A normal level helps rule out a clot in lower-risk people, but a high level is not specific and needs imaging.
Vascular Ultrasound: The primary tool for diagnosing DVT, using sound waves to visualize blood flow in the veins [1].
CT Pulmonary Angiogram (CTPA): The gold standard for identifying clots within the lungs [1].
MRI or Venogram: Used in complex cases where standard imaging is inconclusive [1].
Management and Prevention
The primary goal of VTE treatment is to prevent the clot from growing or breaking loose [1]. This is typically achieved through anticoagulants, often referred to as blood thinners [1]. These medications do not technically "thin" the blood but rather interfere with the clotting process to allow the body to naturally dissolve the obstruction.
Prevention Strategies
Preventing VTE involves maintaining active blood circulation and managing underlying health conditions.
Movement: Avoid sitting for long periods; during long travel, perform leg exercises or take frequent walks [1].
Weight Management: Reducing obesity lowers the pressure on the venous system.
Smoking Cessation: Quitting smoking improves overall vascular health and reduces inflammation.
Medical Prophylaxis: Patients undergoing surgery are often given preventative doses of blood thinners or use compression stockings to maintain blood flow.
Conclusion
Venous Thromboembolism is a silent but potent threat to vascular health, yet it is highly manageable when detected early. By understanding the relationship between Deep Vein Thrombosis and Pulmonary Embolism, individuals can take proactive steps to mitigate their risks. Whether through lifestyle changes like increased movement or medical interventions following surgery, preventing VTE is a critical component of long-term wellness. If symptoms of swelling or respiratory distress arise, prompt clinical evaluation remains the most effective way to ensure a safe and full recovery.
Frequently Asked Questions
Is VTE the same as a heart attack?
No. Heart attacks are caused by clots in the arteries. VTE involves clots in the veins. However, a VTE that travels to the lungs (PE) can cause heart failure.
Can VTE happen to young people?
Yes. While more common in seniors, young people can develop VTE, especially if they use hormonal birth control, are pregnant, or have inherited clotting disorders.
What is the "Economy Class Syndrome"?
The "Economy Class Syndrome" is a term for VTE caused by long-distance travel in cramped conditions, where lack of movement leads to blood pooling and clotting in the legs.
Are blood thinners dangerous?
While they increase the risk of bleeding, they are life-saving for VTE patients. Doctors monitor dosages closely to balance these risks.
Can a DVT dissolve on its own?
Small clots may dissolve, but any suspected DVT requires medical evaluation to prevent it from becoming a life-threatening pulmonary embolism.
How long do I need to take medication?
Most patients take anticoagulants for three to six months, though some with chronic risk factors may need them indefinitely.
Is VTE hereditary?
Some clotting disorders, like Factor V Leiden, are inherited and significantly increase VTE risk. Family history is an important diagnostic factor.
Can I exercise with a DVT?
Early walking is usually encouraged once blood thinners are started; bed rest is generally not needed. Follow your doctor's guidance.
Does VTE always cause pain?
Not always. Some DVTs are "silent" and only discovered if they travel to the lungs and cause respiratory symptoms.
What should I do if I suspect a clot?
Seek medical attention immediately. If you have chest pain or trouble breathing, go to the emergency room or call emergency services.
Related Reading
D-dimer Test: What It Is, Why It's Done, How It Works and What Results Mean explains how a D-dimer blood test is used when DVT or pulmonary embolism is suspected.
Venous Extremity Ultrasound: Checking Arm and Leg Veins for Blood Clots explains the ultrasound that checks arm and leg veins for blood clots.
References
Cleveland Clinic. Venous Thromboembolism. Cleveland Clinic. Last updated February 22, 2022. https://my.clevelandclinic.org/health/diseases/22614-venous-thromboembolism
Bhatt M, Braun C, Patel P, et al. Diagnosis of deep vein thrombosis of the lower extremity: a systematic review and meta-analysis of test accuracy. Blood Advances. 2020;4(7):1250-1264. PMID 32227213. https://doi.org/10.1182/bloodadvances.2019000960
Bellesini M, Robert-Ebadi H, Combescure C, et al. D-dimer to rule out venous thromboembolism during pregnancy: A systematic review and meta-analysis. Journal of Thrombosis and Haemostasis. 2021;19(10):2454-2467. PMID 34161671. https://doi.org/10.1111/jth.15432
Wiegers HMG, Knijp J, van Es N, et al. Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives: Systematic review and meta-analysis. Journal of Thrombosis and Haemostasis. 2022;20(5):1158-1165. PMID 35108438. https://doi.org/10.1111/jth.15661
Medical disclaimer
The information provided in this article is for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Comments